C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2002
08/14/2002	CN1363559A Insulinotropic hormone secretion peptide derivative
08/14/2002	CN1363558A Antibacterial frog skin peptide derivative
08/14/2002	CN1363557A Polypeptide-human myocyte enhancing binding factor 13.31 and polynucleotide for coding it
08/14/2002	CN1089111C New catalase, its gene and composite containing it, and its preparation method
08/13/2002	US6433451 Method and electric motor with rotational stator
08/13/2002	US6433253 Debranching enzymes and DNA sequences coding them, suitable for changing the degree of branching of amylopectin starch in plants
08/13/2002	US6433252 Maize L3 oleosin promoter
08/13/2002	US6433251 Promoter regulating circadian clock function and photoperiodism
08/13/2002	US6433250 Growing plant seed having integrated in its genome recombinant construct comprising functional transcriptional regulatory region and plant oleate-12 hydroxylase sequence, whereby increased percentage of hydroxylated fatty acids is produced
08/13/2002	US6433249 Use of β-glucosidase to enhance disease resistance and resistance to insects in crop plants
08/13/2002	US6433248 Trans-activation of transcription from viral RNA
08/13/2002	US6433247 Bombarding nematode worm with plurality of microprojectiles under conditions to permit microprojectiles to penetrate worm, wherein worm is coated with nucleic acid and is not dehydrated
08/13/2002	US6433160 Method for purification and manipulation of nucleic acids using paramagnetic particles
08/13/2002	US6433159 Oligonucleotide 12-25 nucleotides in length having nucleotide sequence complementary to at least portion of polyprotein translation initiation region of hepatitis c virus genomic or messenger rna, which inhibits translation of rna
08/13/2002	US6433158 Dna comprising polynucleotide encoding polypeptide comprising specified amino acid sequence
08/13/2002	US6433155 Isolated cdna or rna polynucleotide comprising nucleic acid sequence encoding polypeptide comprising specified amino acid sequence, or fragment thereof
08/13/2002	US6433154 Functional receptor/kinase chimera in yeast cells
08/13/2002	US6433153 Human calcium dependent proteases and polynucleotides encoding the same
08/13/2002	US6433149 Compounds and methods for inhibiting cancer metastasis
08/13/2002	US6433148 Immunoglobulin antibodies with amino acid sequences
08/13/2002	US6433143 Tie-2 ligands
08/13/2002	US6433142 Megakaryocyte stimulating factors
08/13/2002	US6433140 Stable bactericidal permeability-increasing protein products and pharmaceutical compositions containing the same
08/13/2002	US6433139 Secreted protein HPEAD48
08/13/2002	US6433138 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
08/13/2002	US6433134 Peptide nucleic acid precursors and methods of preparing same
08/13/2002	US6433017 Amphiphilic polyamine compounds
08/13/2002	US6432927 Compositions and methods for inducing gene expression
08/13/2002	US6432920 Peptide library
08/13/2002	US6432915 Human mitochondrial chaperone protein
08/13/2002	US6432913 Polypeptide of protein p140 and DNAs encoding it
08/13/2002	US6432709 Encapsidation cell lines and expression vectors for transcomplementation of defective retroviral vectors
08/13/2002	US6432708 Human choline acetyltransferase
08/13/2002	US6432705 Isolation of nucleic acid codes multichimeric transactivationfactor polypeptide with domain binding ligands and eukaryotic transcriptional activation domain
08/13/2002	US6432704 Enzymatic rna molecules codes with herpes simplex virus and genes
08/13/2002	US6432703 Isolated polynucleotide sequences
08/13/2002	US6432702 Isolated dna with nucleic acid sequences
08/13/2002	US6432701 Expression cassette, promoters, dna fragments with nucleotide sequences
08/13/2002	US6432700 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
08/13/2002	US6432699 Sindbis viral vectors for transducing target cells for gene encoding a chimeric envelope protein
08/13/2002	US6432696 Fluid control module and temperature controller
08/13/2002	US6432692 Sensitive bioassay for detecting agonists of the aryl hydrocarbon receptor
08/13/2002	US6432690 Cdna codes and isolation mammal proteins and aminno acid sequences
08/13/2002	US6432689 Alkaliphilic and thermophilic microorganisms and enzymes obtained therefrom
08/13/2002	US6432687 Polypeptide amino acid sequence with immunoactive segments
08/13/2002	US6432686 Genetic engineering, fermentation and gene coding
08/13/2002	US6432684 Human nucleotide sequence encode a polypeptide for denaturing polyunsaturated fatty acid
08/13/2002	US6432679 Epstein-barr virus sequence binding to receptors, proteins, polypeptides, peptides or polysaccharides
08/13/2002	US6432678 Isolated polynucleotides with nucleotide sequence
08/13/2002	US6432677 Nucleic acid molecule codes, interferons and amino acid sequences
08/13/2002	US6432676 Insulin production and transformation of cells
08/13/2002	US6432675 Combinatorial polypeptide antigens
08/13/2002	US6432674 Steroid hormone binding protein
08/13/2002	US6432672 Gene conversion as a tool for the construction of recombinant industrial filamentous fungi
08/13/2002	US6432671 Tryparedoxin, expression plasmid, process of production, method of use, test kit, and pharmaceutical composition
08/13/2002	US6432669 Protective recombinant Haemophilus influenzae high molecular weight proteins
08/13/2002	US6432668 Polynucleotides encoding human cyclin-dependent kinase (hPFTAIRE)
08/13/2002	US6432667 Polynucleotide encoding TIE-2 ligand-4
08/13/2002	US6432666 Isolated human dendritic cell receptor with amino acid sequence
08/13/2002	US6432664 Transformation to produce proteins with amino acid sequences
08/13/2002	US6432659 Motor proteins and methods for their use
08/13/2002	US6432655 Binding and 5-ht receptors and gene expression
08/13/2002	US6432648 Administering an asthma drug
08/13/2002	US6432644 Diagnosing polymorphism in humans
08/13/2002	US6432642 Binary probe and clamp composition and methods for a target hybridization detection
08/13/2002	US6432640 P53-induced apoptosis
08/13/2002	US6432636 Detection and quantitation of splice perlecan domain gene
08/13/2002	US6432634 Method, apparatus and kits for sequencing of nucleic acids using multiple dyes
08/13/2002	US6432631 Gene encoding organic anion transporter
08/13/2002	US6432628 Detection of compounds, enzymes, polypeptides and detection of aspartic acid
08/13/2002	US6432410 Morphogenic proteins
08/13/2002	US6432407 Antigenic protein originating in malassezia
08/13/2002	US6432404 Methods of inhibiting locomotor damage following spinal cord injury with α D-specific antibodies
08/13/2002	US6432403 Antibodies to polypeptides having prenylcysteine carboxyl methlytransferase activity or inhibiting activity
08/13/2002	US6432361 Method and apparatus for identifying, classifying, or quantifying protein sequences in a sample without sequencing
08/13/2002	US6432360 Replica amplification of nucleic acid arrays
08/13/2002	CA2328851C Humanized immunoglobulins and their production and use
08/13/2002	CA2228265C Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease
08/13/2002	CA2102387C Gene coded for a polypeptide which enhances virus infections of host insect
08/13/2002	CA2050606C Enzymatic process for the conversion of preproinsulins into insulins
08/13/2002	CA1341382C Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein
08/12/2002	CA2369893A1 Vegf responsive cell-based assay for determining vegf bioactivity
08/09/2002	CA2371447A1 Modified factor viii cdna and its use for the production of factor viii
08/08/2002	WO2002061661A2 Methods for determining protein and peptide terminal sequences
08/08/2002	WO2002061659A2 Computer-assisted means for assessing lifestyle risk factors
08/08/2002	WO2002061435A2 Subunit vaccines with a2 supermotifs
08/08/2002	WO2002061418A1 Method of screening prion disease infection factor
08/08/2002	WO2002061416A1 Hiv and cd4 transgenic animals and uses therefor
08/08/2002	WO2002061389A2 Methods to generate and identify monoclonal antibodies to a large number of human antigens
08/08/2002	WO2002061148A2 Circulating epstein-barr virus dna in the serum of patients with gastric carcinoma
08/08/2002	WO2002061142A2 Methods for homology-driven reassembly of nucleic acid sequences
08/08/2002	WO2002061139A2 Hybridization buffers using low molecular weight dextran sulfate and methods for their use
08/08/2002	WO2002061132A1 Antisense modulation of chk2 expression
08/08/2002	WO2002061130A2 Methods and reagents for analysis of rna structure and function
08/08/2002	WO2002061129A2 Oligonucleotide identifiers
08/08/2002	WO2002061128A2 Method of determining a chemotherapeutic regimen based on ercc1 expression
08/08/2002	WO2002061127A2 Arrayed polynucleotides and their use in genome analysis
08/08/2002	WO2002061126A2 The preparation of polynucleotide arrays
08/08/2002	WO2002061125A2 Immobilised aptamers
08/08/2002	WO2002061121A2 Methods of analysis of nucleic acids

1 ... 2740 2741 2742 2743 2744 2745 2746 2747 2748 2749 2750 2751 2752 2753 2754 2755 2756 2757 2758 2759 2760 ... 4023